1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Comprehensive Assessment of Carbon Dioxide Removal Options for Germany
- Contribution to journal › Article
-
Mark
A storyline approach : integrating comprehensive, interdisciplinary research results to create narratives – in the context of the net-zero target in Germany
- Contribution to journal › Article
- 2022
-
Mark
Scoping carbon dioxide removal options for Germany–What is their potential contribution to Net-Zero CO2?
- Contribution to journal › Article
-
Mark
Net-zero CO2 Germany - A retrospect from the year 2050
- Contribution to journal › Article
- 2015
-
Mark
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
- Contribution to journal › Article
- 2013
-
Mark
A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
- Contribution to journal › Article
- 2009
-
Mark
Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
- Contribution to journal › Article
